Kaneq Bioscience   Report issue

For profit Phase 1
Founded: Baie-d'urfe Canada (2012)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2015
NCT02370043
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Kaneq Bioscience Limited

Active Ingredients

Drugs in Phase 1 Trials (1)

kq-791 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 2 (Phase 1)

Insulin Resistance (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1